Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators. Friedman P, et al. Among authors: birgersdotter green um. N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036522 Clinical Trial.
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Day JD, et al. Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470697 Clinical Trial.
The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
Kawata H, Hirai T, Doukas D, Hirai R, Steinbrunner J, Wilson J, Noda T, Hsu J, Krummen D, Feld G, Wilber D, Santucci P, Birgersdotter-Green U. Kawata H, et al. J Cardiovasc Electrophysiol. 2016 Jun;27(6):724-9. doi: 10.1111/jce.12961. Epub 2016 Apr 20. J Cardiovasc Electrophysiol. 2016. PMID: 26915696
Outcomes of lead extraction without subsequent device reimplantation.
Al-Hijji MA, Killu AM, Yousefian O, Hodge DO, Park JY, Hebsur S, El Sabbagh A, Pretorius VG, Ackerman MJ, Friedman PA, Birgersdotter-Green U, Cha YM. Al-Hijji MA, et al. Europace. 2017 Sep 1;19(9):1527-1534. doi: 10.1093/europace/euw184. Europace. 2017. PMID: 27707785
Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.
Russo RJ, Costa HS, Silva PD, Anderson JL, Arshad A, Biederman RW, Boyle NG, Frabizzio JV, Birgersdotter-Green U, Higgins SL, Lampert R, Machado CE, Martin ET, Rivard AL, Rubenstein JC, Schaerf RH, Schwartz JD, Shah DJ, Tomassoni GF, Tominaga GT, Tonkin AE, Uretsky S, Wolff SD. Russo RJ, et al. N Engl J Med. 2017 Feb 23;376(8):755-764. doi: 10.1056/NEJMoa1603265. N Engl J Med. 2017. PMID: 28225684 Free article.
Reasons for and predictors of acute hospitalization versus elective outpatient implantable cardioverter-defibrillator implantation and subsequent differential clinical outcomes.
Nishimura M, Sab S, Birgersdotter-Green U, Krummen D, Schricker A, Raissi F, Hoffmayer KS, Feld GK, Hsu JC. Nishimura M, et al. J Interv Card Electrophysiol. 2017 Oct;50(1):85-93. doi: 10.1007/s10840-017-0283-1. Epub 2017 Aug 26. J Interv Card Electrophysiol. 2017. PMID: 28844089
138 results